Cargando…

Secretory Leukocyte Protease Inhibitor (SLPI) Is, like Its Homologue Trappin-2 (Pre-Elafin), a Transglutaminase Substrate

Human lungs contain secretory leukocyte protease inhibitor (SLPI), elafin and its biologically active precursor trappin-2 (pre-elafin). These important low-molecular weight inhibitors are involved in controlling the potentially deleterious proteolytic activities of neutrophil serine proteases includ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baranger, Kévin, Zani, Marie-Louise, Labas, Valérie, Dallet-Choisy, Sandrine, Moreau, Thierry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110255/ https://www.ncbi.nlm.nih.gov/pubmed/21687692 http://dx.doi.org/10.1371/journal.pone.0020976

Ejemplares similares

Elafin and its precursor trappin‐2: What is their therapeutic potential for intestinal diseases?
por: Deraison, Céline, et al.
Publicado: (2022)

Differential effects of periopathogens on host protease inhibitors SLPI, elafin, SCCA1, and SCCA2
por: Yin, Lei, et al.
Publicado: (2010)

Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome
por: Dickey, Brittney L., et al.
Publicado: (2021)

Structural and antimicrobial properties of human pre-elafin/trappin-2 and derived peptides against Pseudomonas aeruginosa
por: Bellemare, Audrey, et al.
Publicado: (2010)

Trappin-2/Elafin Modulate Innate Immune Responses of Human Endometrial Epithelial Cells to PolyI∶C
por: Drannik, Anna G., et al.
Publicado: (2012)

Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression
por: Wex, Thomas, et al.
Publicado: (2011)

Increased Secretory Leukocyte Protease Inhibitor (SLPI) Production by Highly Metastatic Mouse Breast Cancer Cells
por: Sayers, Kevin T., et al.
Publicado: (2014)

Anti-Protease Activity Deficient Secretory Leukocyte Protease Inhibitor (SLPI) Exerts Cardioprotective Effect against Myocardial Ischaemia/Reperfusion
por: Mongkolpathumrat, Podsawee, et al.
Publicado: (2022)

Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers
por: Kozin, Sergey V., et al.
Publicado: (2017)

Raised Trappin2/elafin Protein in Cervico-Vaginal Fluid Is a Potential Predictor of Cervical Shortening and Spontaneous Preterm Birth
por: Abbott, Danielle S., et al.
Publicado: (2014)

The antimicrobial molecule trappin-2/elafin has anti-parasitic properties and is protective in vivo in a murine model of cerebral malaria
por: Roussilhon, Christian, et al.
Publicado: (2017)

Plasma concentrations of secretory leukocyte protease inhibitor (SLPI) differ depending on etiology and severity in community-onset bloodstream infection
por: Lange, Anna, et al.
Publicado: (2019)

Endothelial-Cell-Derived Human Secretory Leukocyte Protease Inhibitor (SLPI) Protects Cardiomyocytes against Ischemia/Reperfusion Injury
por: Kongpol, Kantapich, et al.
Publicado: (2019)

Inhibition of secretory leukocyte protease inhibitor (SLPI) promotes the PUMA-mediated apoptosis and chemosensitivity to cisplatin in colorectal cancer cells
por: Wei, Zhijiang, et al.
Publicado: (2023)

Production of secretory leucocyte protease inhibitor (SLPI) in human pancreatic beta-cells.
por: Nyström, M, et al.
Publicado: (1999)

Targeting secretory leukocyte protease inhibitor (SLPI) inhibits colorectal cancer cell growth, migration and invasion via downregulation of AKT
por: Wei, Zhijiang, et al.
Publicado: (2020)

Post-Ischemic Treatment of Recombinant Human Secretory Leukocyte Protease Inhibitor (rhSLPI) Reduced Myocardial Ischemia/Reperfusion Injury
por: Mongkolpathumrat, Podsawee, et al.
Publicado: (2021)

High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence
por: Nugteren, Sandrine, et al.
Publicado: (2022)

Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis
por: Nugteren, Sandrine, et al.
Publicado: (2020)

IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release.
por: Westin, U, et al.
Publicado: (1998)

Evolution of trappin genes in mammals
por: Kato, Akira, et al.
Publicado: (2010)

Secretory Leukocyte Protease Inhibitor (SLPI)—A Novel Predictive Biomarker of Acute Kidney Injury after Cardiac Surgery: A Prospective Observational Study
por: Averdunk, Luisa, et al.
Publicado: (2019)

Transglutaminase binding fusion protein linked to SLPI reduced corneal inflammation and neovascularization
por: Salica, Juan P, et al.
Publicado: (2015)

The presence of elafin, SLPI, IL1-RA and STNFalpha RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation.
por: Westin, U, et al.
Publicado: (2002)

The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease
por: Sallenave, Jean-Michel
Publicado: (2000)

Gelatin-coated silicon oxide nanoparticles encapsulated recombinant human secretory leukocyte protease inhibitor (rhSLPI) reduced cardiac cell death against an in vitro simulated ischaemia/reperfusion injury
por: Pikwong, Faprathan, et al.
Publicado: (2023)

Endogenous secretory leukocyte protease inhibitor inhibits microbial‐induced monocyte activation
por: Nugteren, Sandrine, et al.
Publicado: (2022)

Increased Susceptibility to LPS-induced Endotoxin Shock in Secretory Leukoprotease Inhibitor (SLPI)-deficient Mice
por: Nakamura, Akira, et al.
Publicado: (2003)

How SLPI soothes
por: Van Epps, Heather L.
Publicado: (2005)

Immunoregulatory role of secretory leukocyte protease inhibitor in allergic asthma
por: Marino, Rafael, et al.
Publicado: (2010)

Elafin Reverses Intestinal Fibrosis by Inhibiting Cathepsin S-Mediated Protease-Activated Receptor 2
por: Xie, Ying, et al.
Publicado: (2022)

Effect of Semen on Vaginal Fluid Cytokines and Secretory Leukocyte Protease Inhibitor
por: Agnew, Kathy J., et al.
Publicado: (2008)

The Serine Protease Inhibitor Elafin Maintains Normal Growth Control by Opposing the Mitogenic Effects of Neutrophil Elastase
por: Caruso, Joseph A., et al.
Publicado: (2014)

Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa.
por: Nyström, M, et al.
Publicado: (2001)

Secretory Leukoprotease Inhibitor (Slpi) Expression Is Required for Educating Murine Dendritic Cells Inflammatory Response Following Quercetin Exposure
por: De Santis, Stefania, et al.
Publicado: (2017)

Cementoin–SLPI fusion protein binds to human monocytes and epithelial cells and shows higher biological activity than SLPI
por: Maffía, Paulo C., et al.
Publicado: (2018)

Neutrophil elastase reduces secretion of secretory leukoproteinase inhibitor (SLPI) by lung epithelial cells: role of charge of the proteinase-inhibitor complex
por: Sullivan, Anita L, et al.
Publicado: (2008)

Secretory Leukocyte Protease Inhibitor Is an Inducible Antimicrobial Peptide Expressed in Staphylococcus aureus Endophthalmitis
por: Reviglio, Victor E., et al.
Publicado: (2007)

Human papillomavirus infection in head and neck cancer: The role of the secretory leukocyte protease inhibitor
por: HOFFMANN, MARKUS, et al.
Publicado: (2013)

The cardioprotective effects of secretory leukocyte protease inhibitor against myocardial ischemia/reperfusion injury
por: Prompunt, Eakkapote, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0rbcdi60jkdvgfmo9mp3te8tl3